傅里叶变换红外光谱分析NMDA受体单克隆抗体抗兴奋毒损伤机理

人N-甲基-D-门冬氨酸受体（NMDAR,NR）单克隆抗体MABN1具有明确的抗兴奋毒保护作用,但其机制不明.以MABN1和MK-801分别预处理海马细胞,拮抗谷氨酸兴奋毒损伤作用,采用傅里叶变换红外光谱（FTIR）技术,对不同处理后的海马细胞红外光谱特性进行比较.将去卷积的酰胺Ⅰ带进行曲线拟合后发现,MABN1组与MK-801组的蛋白质二级结构有明显不同,提示二者在抗兴奋毒机制方面存在差别.     

过量皮质酮致原代培养的大鼠海马神经元死亡方式的研究

目的和方法：以体外原代培养的大鼠海马神经元为研究对象,采用原位染色的方法,对不同剂量的皮质酮（CORT）致海马神经元死亡的方式进行研究。结果：在CORT作用下,海马神经元不仅会发生快速的坏死,而且还会发生慢性的凋亡;并且,随着CORT剂量增大和作用时间延长,海马神经元坏死和凋亡的发生率会随之增高。结论：海马神经细胞坏死和凋亡的发生,可能与CORT抑制神经元能量代谢的程度和增高神经元对谷氨酸神经毒性的敏感性有关。     

人参皂甙抗缺氧缺血性脑损伤的谷氨酸相关机制

目的与方法：在离体海马脑片上观察人参皂甙对谷氨酸兴奋性毒性的拮抗作用,在培养的神经细胞和胶质细胞上分别观察人参皂甙对模拟缺血时谷氨酸释放和摄取的影响,以证明人参皂甙缺氧缺血性脑损伤与减少谷氨酸的兴奋神经毒性作用有关。结果：在人工脑脊液中导入谷氨酸（1mmol/L)20min,引起大鼠海马脑片OPS降低直至消失,恢复正常人工脑脊液灌流1h后OPS难以恢复。而使用人参皂甙可促进海马脑片OPS的恢复,作用以20μg/ml剂量组最好。在培养的小鼠皮质神经元和胶质细胞,模拟缺血时神经元谷氨酸释放量对照的数倍,而胶质细胞对谷氨酸的摄取显著减少。使用人参皂甙（20μg/ml）可明显抑制神经元谷氨酸的释放,并促进胶质细胞对谷氨酸的摄取。结论：人参皂甙减少谷氨酸的兴奋性神经毒性作用可能是其抗缺氧缺血性脑损伤的重要机制。     

学习训练对谷氨酸单钠所致大鼠海马损伤的神经保护作用

目的：探讨学习训练对谷氨酸神经毒性的保护作用。方法：在SD大鼠生后第3～9d腹腔注射谷氨酸单钠复制谷氨酸毒性模型,在1月龄和2月龄时训练大鼠学会以明暗辨别来获得食物,3月龄时取脑,在光镜下计数海马内存活神经元数,电镜下观察海马CA1区的超微结构,并计数突触数,测量突触活性带长度。结果：学习训练组海马CA3区和CA4区内的存活神经元数、海马CA1区内的突触数和突触活性带长度均大于非学习组,结论：结果提示学习训练可在一定程度上减轻MSG对海马的损伤。     

白介素-6保护小脑颗粒神经元抗谷氨酸的神经毒性作用

目的：探讨白介素-6（IL-6）对谷氨酸诱导的神经元损伤的防治作用及其作用机制。方法：用IL-6慢性预处理培养的小脑颗粒神经元,然后后用谷氨酸急性刺激小脑颗粒神经元。用噻唑兰（MTT）比色法和末端脱氧核苷酸转移酶介导的原位缺口末端标记（TUNEL）法分别观察神经元的功能和凋亡的变化;用激光扫描共聚焦显微镜（LSCM）和逆转录聚合酶链式反应（RT—PCR）法分别检测神经元内Ca^2＋浓度的动态变化和IL-6信号转导蛋白gp130 mRNA的表达。结果：IL-6（2．5、5和10ng／ml）慢性预处理培养的小脑颗粒神经元,可浓度依赖性地改善谷氨酸诱导的神经元活性降低;并可明显减少谷氨酸诱导的神经元凋亡;还可显著抑制谷氨酸激发的神经元内Ca^2＋超载。此外。经IL-6慢性预处理的小脑颗粒神经元表达gp130mRNA明显低于未经IL-6预处理的神经元。结论：IL-6能保护神经元抵抗由谷氨酸诱导的兴奋毒性作用,IL-6的这种神经保护机制可能与它抑制神经元内Ca^2＋超载密切相关,而且可能由gp130细胞内信号转导途径介导。     

CNTF对烧伤大鼠血清引起大鼠海马神经元细胞毒性的影响

应用整体和离体神经元培养,观察CNTF对烧伤大鼠海马神经元及烧伤血清引起海马神经元损伤的影响,结果表明,大鼠烧伤后海马组织神经元数目减少,NO含量升高;烧伤大鼠血清可引起培养的海马神经元细胞存活率下降,培养液中NO含量升高;CNTF能降低烧伤大鼠海马组织中NO的含量,保护海马神经元,并能提高培养的海马神经元的存活率,减少培养液中NO含量,其作用呈剂量依赖性;CNTF对神经元存活率的影响与NO含量呈显著负相关,提示CNTF对烧伤大鼠血清引起的海马神经元损伤有保护作用,其作用机制可能是通过抑制NO的神经毒性。     

镁离子对谷氨酸诱发的海马神经元损伤的保护作用

目的 :探讨镁离子 (Mg2 )在 0 .1mmol/L谷氨酸诱发的海马神经元损伤中的作用。方法 :将神经元从新生SD大鼠海马中分离后培养 6～ 9d ,即随机分成三组 :A .单纯培养基 ;B .培养基 谷氨酸 ;C .培养基 Mg2 ,30min后再加入谷氨酸。结果 :①B组海马神经元存活率与A组相比显著地呈剂量依赖性降低。②与B组对照 ,C组加用低浓度的Mg2 可提高海马神经元的存活率。结论 :低浓度的Mg2 能保护谷氨酸诱发损伤的海马神经元     

灯盏花素含药血清对谷氨酸致原代海马神经元损伤的影响

目的:从细胞水平研究注射用灯盏花素对谷氨酸致大鼠原代海马神经元损伤的保护作用及其作用机制。方法:采用中药血清药理学方法,制备含药血清;原代培养大鼠乳鼠大脑海马神经元并经鉴定后,以谷氨酸复制损伤模型,以5%含药血清干预,在透射电镜下及经碘化丙啶和Hoechst33342双染后荧光显微镜下观察海马凋亡神经元的形态学变化,并进行检测:MTT法测定细胞存活率,生化法检测LDH漏出率、丙二醛(MDA)含量、细胞释放的NO量、细胞内tNOS活性和iNOS活性。结果:灯盏花素高、低剂量组均能明显增加海马神经元存活率,而LDH漏出率、丙二醛(MDA)含量、一氧化氮释放、总一氧化氮合酶活性和诱导型一氧化氮合酶活性(p<0.05,p<0.01)明显降低。结论:灯盏花素对谷氨酸致原代培养大鼠海马神经元损伤具有保护作用,其作用机制可能与其能改善能量代谢、稳定细胞膜、抗脂质过氧化、降低一氧化氮合酶的活性、减少一氧化氮释放有关。     

人参皂甙Rb3对大鼠海马神经细胞谷氨酸损伤作用及相关机制的研究

目的：利用原代培养的海马神经细胞,研究人参皂甙Rb3对谷氨酸兴奋性神经毒性的保护作用及有关机制。方法：采用原代培养的胚胎大鼠海马神经细胞谷氨酸毒性模型,观察人参皂甙Rb3对神经细胞形态、神经细胞活性、细胞外液中乳酸脱氢酶（lactate dehydrogenase,LDH）的漏出率及总一氧化氮合酶（nitrogen oxide synthase,NOS）、结构型N0s、诱导型NOS活性等的影响。结果：人参皂甙Rb3对神经细胞的谷氨酸毒性损伤具有保护作用。使细胞形态保持完整,活力增加,细胞膜损伤减轻;而且人参皂甙Rb3能增加神经细胞的结构型NOS活性。降低诱导型NOS的活性。结论：人参皂甙Rb,具有抗谷氨酸兴奋性毒性作用,其作用机制可能与降低诱导型NOS活性。增加结构型NOS的活性有关。     

线粒体膜电位与皮质酮对原代培养海马细胞的毒性作用

采用MTT法和激光共聚焦显微术观察皮质酮对原代培养海马神经细胞的存活率及其线粒体膜电位的影响。结果表明,在低糖、无血清培养条件下,皮质酮可剂量依赖地降低海马神经元及神经胶质细胞的存活率,在同等剂量下以神经元损伤更为显著。给予高浓度葡萄糖（25mmol/L）可明显拮抗皮质酮对海马神经元的毒性作用。进一步研究表明,皮质酮（10^-6-10^-5mol/L）可引起海马神经元线粒体膜电位明显下降,此作用亦可被高浓度葡萄糖所对抗。结果提示,在相同处理因素条件下,皮质酮以损伤神经元为主。皮质酮可降低海马神经元的存活率及线粒体膜电位,给予高浓度葡萄糖具有明显的改善作用。线粒体膜电位的下降可能是皮质酮引起神经元损伤的机制之一。     

Dexmedetomidine prevents desflurane-induced motor neuron death through NF-KappaB pathway

Desflurane is one of the commonly used general anaesthetics. Recently, it was reported that desflurane caused neurotoxicity, raising concerns in clinical use. In this study, we found desflurane could affect viability and maturation in motor neurons. Dexmedetomidine, a α2-adrenergic receptor agonist, could attenuate the effect of desflurane on motor neurons. This process was mediated by NF-KappaB signalling. Interestingly, we also found that dexmedetomidine could recover the lesion in motor function and memory impaired by desflurane. Collectively, our results showed the neurotoxic effect of desflurane in motor neurons. More importantly, this process was alleviated by dexmedetomidine, potentially showing its application in protecting motor neuron from neurotoxic agents. Significance of the study: This work provides the evidence to support the protective role of dexmedetomidine in desflurane-induced motor neuron death. Since desflurane is a widely used anaesthetic in surgery and leads to neuron death, the neuroprotective effect of dexmedetomidine holds promising clinical application.     

Apolipoprotein E protects against oxidative stress in mixed neuronal-glial cell cultures by reducing glutamate toxicity

Apolipoprotein E (ApoE) deficiency has been shown to adversely affect outcome after transient cerebral ischemia and head trauma. Since oxidative stress contributes to these injuries, the ability of ApoE to reduce irreversible oxidative damage was studied in primary mixed neuronal-glial cell cultures. Cells (13-16 days in vitro) were exposed to 50 microM hydrogen peroxide (H2O2) for 30 min, and toxicity was determined by the release of lactate dehydrogenase (LDH) 24 h after exposure. The presence of recombinant human ApoE2 (100, 300, or 1000 nM) in the culture media partially protected against oxidative injury. This protection was not reversed by pre-treatment with receptor associated protein. The NMDA receptor antagonist, MK-801, also provided partial protection against H2O2 toxicity. The degree of protection was similar to that conferred by ApoE treatment. The protective effects of ApoE and MK-801 were not additive; no ApoE protection was observed in cultures treated with MK-801 prior to H2O2 exposure. ApoE treatment had no effect on H2O2 stimulated glutamate release, but did increase the rate of glutamate uptake via the high affinity glutamate transporter in H2O2 treated cultures. Pre-treatment with ApoE also conferred partial protection against glutamate-induced LDH release. Taken together, these findings suggest that ApoE protects mixed neuronal-glial cell cultures against irreversible oxidative injury from H2O2 by reducing secondary glutamate excitotoxicity.     

NMDA and Non-NMDA Receptor Gene Expression Following Global Brain Ischemia in Rats: Effect of NMDA and Non-NMDA Receptor Antagonists

Abstract: Transient forebrain or global ischemia in rats induces selective and delayed damage of hippocampal CA1 neurons. In a previous sludy, we have shown that expression of GIuR2, the kainate/a-amino-3-hydroxy-5- methyl-4-isoxazolepropionic acid (AMPA) receptor subunit that governs Ca' permeability, is preferentially reduced in CA1 at a time point proceeding neuronal degeneration. Postischemic administration of the selective AMPA receptor antagonist, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX), protects CAI neurons against delayed death. In this study we examined the effects of NBQX (at a neuroprotective dose) and of MK-801 (a selective NMDA receptor anltagonist, not protective in this model) on kainate/AMPA receptor gene expression changes after global ischemia. We also examined the effects of transient forebrain ischemia on expression of the NMDA receptor subunit NMDARI. In ischemic rats treated with saline, GIuR2 and (31uR3 mRNAs were markedly reduced in CAI but were unchanged in CA3 or dentate gyrus. GluRl and NMDAR1 mRNAs were not significantly changed in any region examined. Administration of NBQX or MK-801 did not alter the ischemia-induced changes in kainate/AMPA receptor gene expression. These findings suggest that NBQX affords neuroprotection by a direct blockade of kainate/AMPA receptors, rather than by a modificatian of GIuR2 expression changes     

皮质酮对原代培养海马神经元的毒性作用及NMDA受体亚基表达的改变

目的研究皮质酮对大鼠海马神经元的毒性作用及NMDA受体亚基表达的影响.方法以体外原代培养的大鼠海马神经元为研究对象,根据影响因素,即给予的不同浓度皮质酮和其它因素分为8个组:对照组、10-7mol/L皮质酮组(简称10-7组)、10-6mol/L皮质酮组(简称10-6组)、10-5mol/L皮质酮组(简称10-5组)、10-6 高糖组、10-5 高糖组、10-6mol/L MK801组和10-5mol/L MK801组,镜下观察不同浓度皮质酮作用下海马神经元形态学的变化,并采用MTT方法测量各组细胞存活率,利用免疫细胞化学结合图象分析对原代培养海马神经元NMDA受体亚基的表达进行观察.结果 10-6、10-5浓度的皮质酮对海马神经元影响较大,细胞存活率较对照组明显降低,但10-6 高糖组、 10-5mol/L 高糖组、10-6mol/L MK801及10-5mol/L MK801 4个组,分别与相同皮质酮浓度处理组比较,细胞存活率显著提高.10-6和10-5组海马神经元上NMDA受体亚基表达较对照组明显降低.10-7mol/L浓度的皮质酮对上述指标影响不大.结论过量的皮质酮对大鼠海马神经元具有损伤作用,NMDA受体参与了此过程,NMDA受体拮抗剂和高浓度葡萄糖可保护海马神经元.     

睫状神经营养因子对应激引起大鼠海马神经元损伤的保护作用及其机制的研究

本实验用Ｎｉｓｓｌ染色法、Ｂｉｅｌｓｃｈｏｗｓｋｙ－Ｇｒｏｓ－Ｌａｗｒｅｎｔｊｅｗ染色法、常规透射电镜、行为活动测定、双侧海马微量给药、海马神经元原代培养、活细胞连续照相、全细胞膜片钳记录、细胞内游离Ｃａ＾２＋浓度测定及Ｐ５３蛋白免疫组化测定等方法,观察了睫状神经营养因子（ＣＮＴＦ）对应激引起动物行为变化和海马神经元形态学变化的影响,探讨了ＣＮＴＦ的部分作用机制。结果表明,急性应激不引起大鼠海马神     

l-Deprenyl Protects Mesencephalic Dopamine Neurons from Glutamate Receptor-Mediated Toxicity In Vitro

Abstract: l -Deprenyl is a relatively selective inhibitor of monoamine oxidase (MAO)-B that delays the emergence of disability and the progression of signs and symptoms of Parkinson's disease. Experimentally, deprenyl has also been shown to prevent neuronal cell death in various models through a mechanism that is independent of MAO-B inhibition. We examined the effect of deprenyl on cultured mesencephalic dopamine neurons subjected to daily changes of feeding medium, an experimental paradigm that causes neuronal death associated with activation of the NMDA subtype of glutamate receptors. Both deprenyl (0.5–50 µ M ) and the NMDA receptor blocker MK-801 (10 µ M ) protected dopamine neurons from damage caused by medium changes. The nonselective MAO inhibitor pargyline (0.5–50 µ M ) was not protective, indicating that protection by deprenyl was not due to MAO inhibition. Deprenyl (50 µ M ) also protected dopamine neurons from delayed neurotoxicity caused by exposure to NMDA. Because deprenyl had no inhibitory effect on NMDA receptor binding, it is likely that deprenyl protects from events occurring downstream from activation of glutamate receptors. As excitotoxic injury has been implicated in neurodegeneration, it is possible that deprenyl exerts its beneficial effects in Parkinson's disease by suppressing excitotoxic damage.     

In vivo neuroprotective role of NMDA receptors against kainate-induced excitotoxicity in murine hippocampal pyramidal neurons

Activation of NMDA receptors has been shown to induce either neuronal cell death or neuroprotection against excitotoxicity in cultured cerebellar granule neurons in vitro. We have investigated the effects of pretreatment with NMDA on kainate-induced neuronal cell death in mouse hippocampus in vivo. The systemic administration of kainate (30 mg/kg), but not NMDA (100 mg/kg), induced severe damage in pyramidal neurons of the hippocampal CA1 and CA3 subfields 3-7 days later, without affecting granule neurons in the dentate gyrus. An immunohistochemical study using an anti-single-stranded DNA antibody and TdT-mediated dUTP nick end labeling analysis both revealed that kainate, but not NMDA, induced DNA fragmentation in the CA1 and CA3 pyramidal neurons 1-3 days after administration. Kainate-induced neuronal loss was completely prevented by the systemic administration of NMDA (100 mg/kg) 1 h to 1 day previously. No pyramidal neuron was seen with fragmented DNA in the hippocampus of animals injected with kainate 1 day after NMDA treatment. The neuroprotection mediated by NMDA was prevented by the non-competitive NMDA receptor antagonist MK-801. Taken together these results indicate that in vivo activation of NMDA receptors is capable of protecting against kainate-induced neuronal damage through blockade of DNA fragmentation in murine hippocampus.     

ACEA改善线粒体复合体活性诱导神经保护作用研究

目的:探讨线粒体复合体活性对大麻素CB1受体选择性激动剂ACEA神经保护作用的影响。方法:将原代大鼠皮层神经元分为4组:对照组(Control)、氧糖剥夺组(OGD)、ACEA+OGD组和溶剂(Vehicle)+OGD组,分别检测各组神经元损伤程度和线粒体复合体Ⅰ、Ⅱ和Ⅳ的活性。为进一步证实线粒体复合体活性对ACEA神经保护的影响,将原代大鼠皮层神经元分为5组:对照组(Control)、氧糖剥夺组(OGD)、ACEA+OGD组、线粒体复合体Ⅰ抑制剂(rotenone)+ACEA+OGD组和线粒体复合体Ⅱ抑制剂(TTFA)+ACEA+OGD组,检测和比较各组神经元细胞的损伤情况。结果:在OGD后24小时,ACEA明显增加神经元活性,减少LDH释放,降低神经元凋亡率(P0.05),改善OGD损伤后线粒体复合体Ⅰ和Ⅳ的活性(P0.05),而对复合体Ⅱ的活性没有影响;rotenone可以部分逆转ACEA的神经保护作用(P0.05),但TTFA却没有这一作用。结论:ACEA可以诱导神经保护作用,其机制是与改善线粒体呼吸链复合体活性有关。     

N-methyl-D-aspartate receptor antagonists enhance histamine neuron activity in rodent brain

The modulation of histamine neuron activity by various non-competitive NMDA-receptor antagonists was evaluated by changes in tele-methylhistamine (t-MeHA) levels and histidine decarboxylase (hdc) mRNA expression induced in rodent brain. The NMDA open-channel blockers phencyclidine (PCP) and MK-801 enhanced t-MeHA levels in mouse brain by 50-60%. Ifenprodil, which interacts with polyamine sites of NR2B-containing NMDA receptors, had no effect. PCP also increased hdc mRNA expression in the rat tuberomammillary nucleus. The enhancement of t-MeHA levels elicited by MK-801 (ED50 of approximately 0.1 mg/kg) was observed in the hypothalamus, cerebral cortex, striatum and hippocampus. Control t-MeHA levels and the t-MeHA response to MK-801 were not different in male and female mice. Double immunostaining for HDC and NMDA receptor subunits showed that histamine neurons of the rat tuberomammillary nucleus express NMDA receptor subunit 1 (NR1) with NMDA receptor subunit 2A (NR2A) and NMDA receptor 2B subunit (NR2B). In addition, immunoreactivity for the neuronal glutamate transporter EAAC1 was observed near most histaminergic perikarya. Hence, these findings support the existence of histamine/glutamate functional interactions in the brain. The increase in histamine neuron activity induced by NMDA receptor antagonists further suggests a role of histamine neurons in psychotic disorders. In addition, the decrease in MK-801-induced hyperlocomotion observed in mice after administration of ciproxifan further strengthens the potential interest of H3-receptor antagonist/inverse agonists for the symptomatic treatment of schizophrenia.     

血管紧张素1-7对氧糖剥夺/复氧海马神经元的保护作用

血管紧张素1-7（angiotensin 1-7, Ang1-7）在神经系统中发挥重要作用。已有研究发现,Ang1-7在脑缺血动物模型中发挥保护作用,但至今未见有关Ang1-7对氧糖剥夺/复氧（oxygen-glucose deprivation/ reoxygenation, OGD/R）损伤神经元的保护作用及其机制的研究报道。本研究以厌氧培养及不含葡萄糖的EBSS培养基培养、建立新生大白鼠原代培养的海马神经元OGD/R模型模拟脑缺血环境,实验分为3组：正常对照组、实验对照组和Ang1-7处理组。倒置显微镜观察神经元形态显示,Ang1-7处理组的神经元形态明显改善|CCK8试剂盒检测发现,Ang1-7处理组的细胞活性提高|流式细胞术研究发现,Ang1-7处理组的神经元凋亡和坏死率降低、神经元内Ca2+及NO水平降低|Western印迹结果发现,Ang1-7处理组Bax表达降低,Bcl-2表达增加。以上结果说明,Ang1-7可降低OGD/R神经元中NO和Ca2+水平,降低Bax蛋白、增加Bcl-2蛋白的表达,减少OGD/R神经元凋亡和坏死率,对OGD/R神经元发挥了保护作用。本研究为进一步在神经元水平上研究Ang-1-7的保护机制奠定基础,对中风等脑缺血疾病的防治具有重要意义。